The Republican Fausts Something for everybody,

New Post Public Reply Private Reply Replies (0) Message Board
Bhawks
209
Quote:
The Republican Fausts

Something for everybody, including you Roy, in this editorial from a conservative.

Long story short, you righties were so desperate for a 'win' you struck a bargain with a patently unqualified, thin skinned borderline sociopath. You sowed the wind, welcome to the whirlwind.

“To say that it is amateur hour at the White House is to slander amateurs. The recent executive orders were drafted and signed without any normal agency review or even semi-coherent legal advice, filled with elemental errors that any nursery school student would have caught.”

David Brooks JAN. 31, 2017

Many Republican members of Congress have made a Faustian bargain with Donald Trump. They don’t particularly admire him as a man, they don’t trust him as an administrator, they don’t agree with him on major issues, but they respect the grip he has on their voters, they hope he’ll sign their legislation and they certainly don’t want to be seen siding with the inflamed progressives or the hyperventilating media.

Their position was at least comprehensible: How many times in a lifetime does your party control all levers of power? When that happens you’re willing to tolerate a little Trumpian circus behavior in order to get things done.

But if the last 10 days have made anything clear, it’s this: The Republican Fausts are in an untenable position. The deal they’ve struck with the devil comes at too high a price. It really will cost them their soul.

You lost me there, Brooksy. What a presumption, that the GOP Fausts, moral imbeciles and empathy-challenged sociopaths on their best day, have a 'soul'? LOL!

In the first place, the Trump administration is not a Republican administration; it is an ethnic nationalist administration. Trump insulted both parties equally in his Inaugural Address. The Bannonites are utterly crushing the Republican regulars when it comes to actual policy making.

The administration has swung sharply antitrade. Trump’s economic instincts are corporatist, not free market. If Barack Obama tried to lead from behind, Trump’s foreign policy involves actively running away from global engagement.

Outspoken critics of Paul Ryan are being given White House jobs, and at the same time, if Reince Priebus has a pulse it is not externally evident.

Second, even if Trump’s ideology were not noxious, his incompetence is a threat to all around him. To say that it is amateur hour at the White House is to slander amateurs.

The recent executive orders were drafted and signed without any normal agency review or even semi-coherent legal advice, filled with elemental errors that any nursery school student would have caught.

It seems that the Trump administration is less a government than a small clique of bloggers and tweeters who are incommunicado with the people who actually help them get things done. Things will get really hairy when the world’s problems are incoming.

Third, it’s becoming increasingly clear that the aroma of bigotry infuses the whole operation, and anybody who aligns too closely will end up sharing in the stench.

The administration could have simply tightened up the refugee review process and capped the refugee intake at 50,000, but instead went out of its way to insult Islam. The administration could have simply tightened up immigration procedures, but Trump went out of his way to pick a fight with all of Mexico.

Other Republicans have gone far out of their way to make sure the war on terrorism is not a war on Islam or on Arabs, but Trump has gone out of his way to ensure the opposite. The racial club is always there.

Fourth, it is hard to think of any administration in recent memory, on any level, whose identity is so tainted by cruelty. The Trump administration is often harsh and never kind. It is quick to inflict suffering on the 8-year-old Syrian girl who’s been bombed and strafed and lost her dad. Its deportation vows mean that in the years ahead, the TV screens will be filled with weeping families being pulled apart.

None of these traits will improve with time. As former Bush administration official Eliot Cohen wrote in The Atlantic, “Precisely because the problem is one of temperament and character, it will not get better.

It will get worse, as power intoxicates Trump and those around him. It will probably end in calamity — substantial domestic protest and violence, a breakdown of international economic relationships, the collapse of major alliances, or perhaps one or more new wars (even with China) on top of the ones we already have.

It will not be surprising in the slightest if his term ends not in four or in eight years, but sooner, with impeachment or removal under the 25th Amendment.”

The danger signs are there in profusion. Sooner or later, the Republican Fausts will face a binary choice. As they did under Nixon, Republican leaders will have to either oppose Trump and risk his tweets, or sidle along with him and live with his stain.

Trump exceeded expectations with his cabinet picks, but his first 10 days in office have made clear this is not a normal administration. It is a problem that demands a response. It is a callous, bumbling group that demands either personal loyalty or the ax.

Already one sees John McCain and Lindsey Graham forming a bit of a Republican opposition. The other honorable senators will have to choose: Collins, Alexander, Portman, Corker, Cotton, Sasse and so on and so on.

With most administrations you can agree sometimes and disagree other times. But this one is a danger to the party and the nation in its existential nature. And so sooner or later all will have to choose what side they are on, and live forever after with the choice.

Ami
Portland Oregon 16 hours ago

Thank you for this position. I know as a life long Republican this could not have been easy for you to write. The Republican party has a choice, they can put country before party and stand up to the bully who calls himself a Republican president or they can make excuses for him hoping he will throw them a bone and pass legislation they care about. The American people are watching closely.

Some things that the Republicans need to keep in mind as they make their decision. Trump lost by 3 million votes so he doesn't have a mandate. Despite what fox news reports there were women's marches in all 50 states. When people march in conservative states Republicans need to pay attention. Also, Trump will eventually turn on the Republican party. He's not really a Republican, he just used their platform to get elected.

We're a nation made up of people who are united in our differences. Each part of the country has different priorities and beliefs but the one thing we all agree on is that we are Americans first. As Americans we are proud of the fact that we are a nation of laws. We are not deliberately cruel.

If Americans feel that the only way to control Trump is to vote Republicans out of office in the mid terms we will do so. Republicans need to decide what they are going to do quickly. Trump will define the Republican party for a generation if they don't act soon.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 165

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 58

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
Princess Cruises Launches New Era at Celebration Key

Updated Category News Views 153

Never thought I'd see the day when a cruise ship docking would stir such excitement, but here we are. The Star Princess has made its grand debut at Celebration Key, the latest jewel in Princess Cruises' crown. And they're going all out with Bahamian flair—something about a Junkanoo band and beach art that would make even the crustiest sailor crack a smile. Inaugural Fun...

Continue Reading
Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026

Updated Category News Views 63

A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...

Continue Reading
Beef 'O' Brady's Expands Into Tuscaloosa Market

Updated Category News Views 148

A New Player in Town: Beef 'O' Brady's Lands in Tuscaloosa Listen up, sports fans and pub grub lovers of Tuscaloosa! Beef 'O' Brady's just kicked down the doors and expanded its reach, opening a location smack on McFarland Boulevard. The place threw open its doors on October 26 and is set to make waves in the local scene, driven by the dedicated hands of Mitul Patel and...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 239

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 247

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 211

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 89

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 410

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading

Top 5 Most Recently Viewed Articles

Tech Titans Rally: Stock Highlights You Can't Miss Today

Updated Category News Views 204

Market Overview Recent trading sessions in the U.S. saw mixed results. While the Dow Jones Industrial Average experienced a slight decline, the S&P 500 showed minimal movement. In contrast, the tech-centered Nasdaq showed a modest uptick as many companies presented their earnings. Federal Reserve Updates The Federal Reserve's decision to hold interest rates steady at...

Continue Reading
Investment Growth: Alphabet Stock's Journey Over Two Decades

Updated Category News Views 265

Understanding the Performance of Alphabet Stock Alphabet (NASDAQ: GOOGL) has consistently demonstrated remarkable growth, outpacing the market by an impressive 9.36% on an annualized basis. This translates to an average annual return of 18.3%, showcasing the company's ability to thrive even amid challenging economic conditions. With a market capitalization soaring to...

Continue Reading
Palantir Technologies Expands with 26 Partnerships in 15 Sectors

Updated Category News Views 885

Palantir's Remarkable Growth Journey Palantir Technologies Inc (NASDAQ: PLTR) has been making waves in the enterprise software landscape. In merely ten months, the company has successfully formed 26 partnerships across 15 different sectors, a feat that extends its reach well beyond its traditional defense-oriented image. This surge in collaboration indicates its...

Continue Reading
Bitcoin Market Dynamics Shift Amidst Emerging Trends

Updated Category News Views 148

Bitcoin Market Dynamics Shift Amidst Emerging Trends The financial markets are currently navigating through a phase of cautious optimism, with the leading indices showing modest gains. A notable exception to this trend is Bitcoin, which has recently displayed some volatility. After a significant breakout, Bitcoin encountered a sudden reverse, leading to concerns of a...

Continue Reading
Stifel Financial Corp. Announces Cash Dividends for Investors

Updated Category News Views 129

Stifel Financial Corporation's Dividend Announcement Stifel Financial Corp. announces a substantial cash dividend for its common stock shareholders, declaring a payout of $0.46 per share. This announcement comes as part of the company's regular financial strategy aimed at rewarding its shareholders. The payment is scheduled for September 16, with shareholders on record as...

Continue Reading